Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26F61A8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,926
Award facts
- Contract value 100% obligated
- $22,926.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,926.45 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on November 13, 2025, with an ultimate completion date of November 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly supplies critical medications to federal healthcare systems including the Defense Health Agency and U.S. Coast Guard through its DLA relationship. The company's federal procurement portfolio demonstrates substantial experience fulfilling diverse pharmaceutical needs across multiple therapeutic domains, from specialty medications to vaccines and medical supplies. This particular delivery order for Otezla, a dermatological immunosuppressant commonly used to treat psoriasis and psoriatic arthritis, reflects the company's established capability to meet federal medical supply requirements through open competition and firm fixed-price arrangements.
Quick answers
Who was awarded contract SPE2DR26F61A8?
SPE2DR26F61A8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F61A8 worth?
The government has obligated $22,926 on SPE2DR26F61A8.
Is contract SPE2DR26F61A8 an order under another contract?
Yes. SPE2DR26F61A8 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F61A8 competed?
The extent of competition for SPE2DR26F61A8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award